Successful management of intractable cryptosporidial diarrhea with intravenous octreotide, a somatostatin analogue

Louis M. Weiss, Ora Burstein, Michael Landor, Larry Bernstein, Louis M. Weiss, Murray Wittner

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

A 38-year-old man with AIDS and intractable large-volume diarrhea due to a cryptosporidial infection was successfully treated with intravenous octreotide, a somatostatin analogue. The volume of diarrhea, 10-12 liters with 8-13 movements per day, was reduced to three to four semi-formed to formed stools per day when the patient was treated with 400 μg intravenous octreotide daily. The patient's intravenous hyperalimentation was discontinued and he returned to oral feeding. He quickly regained his normal weight and has now resumed his normal activites. For those patients who cannot tolerate subcutaneous administration, intravenous octreotide therapy may not only be life-saving but may also markedly increase the quality of life. Roxithromycin, a macrolide antibiotic, was also administered to this patient with cryptosporidiosis but efficacy was not demonstrated.

Original languageEnglish (US)
Pages (from-to)765-767
Number of pages3
JournalAIDS
Volume5
Issue number6
StatePublished - Jun 1991

Fingerprint

Octreotide
Somatostatin
Diarrhea
Roxithromycin
Cryptosporidiosis
Total Parenteral Nutrition
Macrolides
Intravenous Administration
Acquired Immunodeficiency Syndrome
Quality of Life
Anti-Bacterial Agents
Weights and Measures
Infection
Therapeutics

Keywords

  • Cryptosporidiosis
  • Diarrhea
  • Octreotide
  • Roxithromycin

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Weiss, L. M., Burstein, O., Landor, M., Bernstein, L., Weiss, L. M., & Wittner, M. (1991). Successful management of intractable cryptosporidial diarrhea with intravenous octreotide, a somatostatin analogue. AIDS, 5(6), 765-767.

Successful management of intractable cryptosporidial diarrhea with intravenous octreotide, a somatostatin analogue. / Weiss, Louis M.; Burstein, Ora; Landor, Michael; Bernstein, Larry; Weiss, Louis M.; Wittner, Murray.

In: AIDS, Vol. 5, No. 6, 06.1991, p. 765-767.

Research output: Contribution to journalArticle

Weiss, LM, Burstein, O, Landor, M, Bernstein, L, Weiss, LM & Wittner, M 1991, 'Successful management of intractable cryptosporidial diarrhea with intravenous octreotide, a somatostatin analogue', AIDS, vol. 5, no. 6, pp. 765-767.
Weiss LM, Burstein O, Landor M, Bernstein L, Weiss LM, Wittner M. Successful management of intractable cryptosporidial diarrhea with intravenous octreotide, a somatostatin analogue. AIDS. 1991 Jun;5(6):765-767.
Weiss, Louis M. ; Burstein, Ora ; Landor, Michael ; Bernstein, Larry ; Weiss, Louis M. ; Wittner, Murray. / Successful management of intractable cryptosporidial diarrhea with intravenous octreotide, a somatostatin analogue. In: AIDS. 1991 ; Vol. 5, No. 6. pp. 765-767.
@article{1d87b4c48d5a46e1941987d60e6e0e28,
title = "Successful management of intractable cryptosporidial diarrhea with intravenous octreotide, a somatostatin analogue",
abstract = "A 38-year-old man with AIDS and intractable large-volume diarrhea due to a cryptosporidial infection was successfully treated with intravenous octreotide, a somatostatin analogue. The volume of diarrhea, 10-12 liters with 8-13 movements per day, was reduced to three to four semi-formed to formed stools per day when the patient was treated with 400 μg intravenous octreotide daily. The patient's intravenous hyperalimentation was discontinued and he returned to oral feeding. He quickly regained his normal weight and has now resumed his normal activites. For those patients who cannot tolerate subcutaneous administration, intravenous octreotide therapy may not only be life-saving but may also markedly increase the quality of life. Roxithromycin, a macrolide antibiotic, was also administered to this patient with cryptosporidiosis but efficacy was not demonstrated.",
keywords = "Cryptosporidiosis, Diarrhea, Octreotide, Roxithromycin",
author = "Weiss, {Louis M.} and Ora Burstein and Michael Landor and Larry Bernstein and Weiss, {Louis M.} and Murray Wittner",
year = "1991",
month = "6",
language = "English (US)",
volume = "5",
pages = "765--767",
journal = "AIDS",
issn = "0269-9370",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Successful management of intractable cryptosporidial diarrhea with intravenous octreotide, a somatostatin analogue

AU - Weiss, Louis M.

AU - Burstein, Ora

AU - Landor, Michael

AU - Bernstein, Larry

AU - Weiss, Louis M.

AU - Wittner, Murray

PY - 1991/6

Y1 - 1991/6

N2 - A 38-year-old man with AIDS and intractable large-volume diarrhea due to a cryptosporidial infection was successfully treated with intravenous octreotide, a somatostatin analogue. The volume of diarrhea, 10-12 liters with 8-13 movements per day, was reduced to three to four semi-formed to formed stools per day when the patient was treated with 400 μg intravenous octreotide daily. The patient's intravenous hyperalimentation was discontinued and he returned to oral feeding. He quickly regained his normal weight and has now resumed his normal activites. For those patients who cannot tolerate subcutaneous administration, intravenous octreotide therapy may not only be life-saving but may also markedly increase the quality of life. Roxithromycin, a macrolide antibiotic, was also administered to this patient with cryptosporidiosis but efficacy was not demonstrated.

AB - A 38-year-old man with AIDS and intractable large-volume diarrhea due to a cryptosporidial infection was successfully treated with intravenous octreotide, a somatostatin analogue. The volume of diarrhea, 10-12 liters with 8-13 movements per day, was reduced to three to four semi-formed to formed stools per day when the patient was treated with 400 μg intravenous octreotide daily. The patient's intravenous hyperalimentation was discontinued and he returned to oral feeding. He quickly regained his normal weight and has now resumed his normal activites. For those patients who cannot tolerate subcutaneous administration, intravenous octreotide therapy may not only be life-saving but may also markedly increase the quality of life. Roxithromycin, a macrolide antibiotic, was also administered to this patient with cryptosporidiosis but efficacy was not demonstrated.

KW - Cryptosporidiosis

KW - Diarrhea

KW - Octreotide

KW - Roxithromycin

UR - http://www.scopus.com/inward/record.url?scp=0025727089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025727089&partnerID=8YFLogxK

M3 - Article

C2 - 1883548

AN - SCOPUS:0025727089

VL - 5

SP - 765

EP - 767

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 6

ER -